A Single Ascending Dose Study of DT-216P2 in Normal Healthy Participants
Clinical trial NCT06772870 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06772870
- Sponsor
- Design Therapeutics, Inc.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-02-01
- Primary completion
- 2025-09-01
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.